The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab (atezo) vs. chemotherapy (chemo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Immune biomarkers, tumor mutational burden (TMB), and clinical outcomes from the phase III IMvigor211 study.
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Yohann Loriot
Consulting or Advisory Role - Astellas Oncology; Janssen; MSD; Roche; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD; Roche
 
Alain Ravaud
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Caris Life Sciences; Fujifilm; Genentech/Roche; HERON; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Sanofi
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; US Oncology
 
Ignacio Duran
Honoraria - Bristol-Myers Squibb; Ipsen
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech; Sanofi
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Margitta Retz
No Relationships to Disclose
 
Ugo De Giorgi
No Relationships to Disclose
 
Stephane Oudard
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Oncology; Sanofi
 
Aristotelis Bamias
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Pierre Fabre
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Hartmut Koeppen
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Ning Leng
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Edward E. Kadel
Employment - Genentech Mypath
Stock and Other Ownership Interests - Genentech
 
Priti S. Hegde
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Na Cui
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Xiaodong Shen
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Christina Louise Derleth
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Marjorie C. Green
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Romain Banchereau
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Sanjeev Mariathasan
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Michiel Simon Van Der Heijden
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis